Abstract
Purpose: A case of acute pancreatitis with severe hypertriglyceridemia occurred following use of intramuscular estradiol valerate during endometrial preparation for cryopreserved embryos.
Methods: A 30-year-old woman with primary infertility and a past history of well-controlled hypothyroidism, underwent endometrial development with intramuscular estradiol valerate in preparation for the transfer of cryopreservred embryos.
Results: Initial hospitalization, discontinuation of all estrogens, aggressive intravenous fluid hydration, and initiation of low-fat diet with additional gemfibrozil treatment resulted in complete resolution of all symptoms related to the pancreatitis including the hyperlipidemia. A subsequent cryothaw cycle using oral estradiol resulted in a viable pregnancy with only mild increases in the patient's triglyceride and cholesterol levels noted throughout her 38-week gestation.
Conclusion(s): Estradiol valerate, a commonly used form of estrogen for endometrial preparation during cryothaw cycles, may cause severe hypertriglyceridemia and acute pancreatitis in certain predisposed individuals. Oral and transdermal estrogens should be the preferred method of endometrial preparation in patients at high risk for lipid metabolism disorders, such as patients with polycystic ovarian syndrome and familial hypertriglyceridemia. These estrogens are more rapidly metabolized and have a shorter half life compared to that of estradiol valerate.
Keywords: Estradiol valerate, hypertriglyceridemia, infertility, pancreatitis
Full Text
The Full Text of this article is available as a PDF (49.1 KB).
REFERENCES
- 1.Zorrilla E, Hulse J, Hernandez A, Gershberg H. Severe endogenous hypertriglyceridemia during treatment with estrogens and oral contraceptives. Clin Endocrinol. 1968;22:755–760. doi: 10.1210/jcem-28-12-1793. [DOI] [PubMed] [Google Scholar]
- 2.Hsia SH, Connelly PW, Hegele RA. Successful outcome in severe pregnancy-associated hyperlipemia: A case report and literature review. Am J Med Sci. 1995;309:213–218. doi: 10.1097/00000441-199504000-00005. [DOI] [PubMed] [Google Scholar]
- 3.Molitch ME, Oill P, Odell WD. Massive hyperlipemia during estrogen therapy. JAMA. 1974;227:522–525. [PubMed] [Google Scholar]
- 4.Hozumi Y, Kawano M, Miyata M. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery. Endocr J. 1997;44:745–749. doi: 10.1507/endocrj.44.745. [DOI] [PubMed] [Google Scholar]
- 5.Glueck CJ, Lang J, Hamer T, Tracy T. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med. 1994;123:59–64. [PubMed] [Google Scholar]
- 6.Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979;133:165–170. doi: 10.1016/0002-9378(79)90469-1. [DOI] [PubMed] [Google Scholar]
- 7.Castro MR, Nguyen TT, O’Brien T. Clomiphene-induced severe hypertriglyceridemia and pancreatitis. Mayo Clin Proc. 1999;74:1125–1128. doi: 10.4065/74.11.1125. [DOI] [PubMed] [Google Scholar]
- 8.Chait A, Brunzell JD. Severe hypertriglyceridemia: Role of familial and acquired disorders. Metabolism. 1983;22:209–214. doi: 10.1016/0026-0495(83)90184-1. [DOI] [PubMed] [Google Scholar]
- 9.Swoboda K, Derfler K, Koppensteiner R, Langer M, Pamberger P, Brehm R, Ehringer H, Druml W, Widhalm K. Extracorpeal lipid elimination for treatment of gestational hyperlipidemic pancreatitis. Gastroenterology. 1993;104:1527–1531. doi: 10.1016/0016-5085(93)90366-k. [DOI] [PubMed] [Google Scholar]